Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.451
+0.011 (2.50%)
At close: Dec 20, 2024, 4:00 PM
0.440
-0.011 (-2.46%)
After-hours: Dec 20, 2024, 5:51 PM EST
Ainos Employees
Ainos had 46 employees as of December 31, 2023. The number of employees increased by 3 or 6.98% compared to the previous year.
Employees
46
Change (1Y)
3
Growth (1Y)
6.98%
Revenue / Employee
$883
Profits / Employee
-$350,732
Market Cap
6.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Syra Health | 162 |
| PAVmed | 107 |
| Ontrak | 104 |
| Plus Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Galecto | 13 |
| Alzamend Neuro | 7 |
| CNS Pharmaceuticals | 5 |
AIMD News
- 3 days ago - CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 3 days ago - Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 8 days ago - Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement - Accesswire
- 17 days ago - Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing - Accesswire
- 19 days ago - Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug - Newsfile Corp
- 5 weeks ago - Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments - Accesswire
- 5 weeks ago - Ainos Announces IRB Approval for Sjögren's Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025 - Accesswire
- 6 weeks ago - Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities - Accesswire